Table 2 Clinical and biological features of HTLV-1-infected patients with connective tissue disease
Patient | Sex | Age | Connective tissue disease | Associated diseases | Disease duration (year) | ESR (mm) | CRP (mg/l) | ANA | Treatment | HTLV-1 proviral load (copies / 106 PBMCs) |
|---|---|---|---|---|---|---|---|---|---|---|
13 | F | 38 | SLE | uveitis | 13 | 38 | 6 | + | Corticosteroids, HC | 18,400 |
14 | F | 68 | PM | - | 1 | 17 | 1 | + | Corticosteroids | 411,200 |
15 | F | 60 | SS | - | 2 | 10 | 1 | + | NSAIDs, HC | 1,500 |
16 | F | 56 | PM | HAM/TSP | 10 | 17 | 12 | + | Corticosteroids | 71,700 |
17 | F | 63 | SS | - | 3 | 22 | 15 | + | NSAIDs, HC | 169,900 |
18 | F | 65 | SS | HAM/TSP, alveolitis | 5 | 21 | 1 | - | Corticosteroids | 362,300 |